ESC Premium Access

New treatment studies in heart failure

Event: ESC CONGRESS 2019
Topic: Treatment
Session type: Rapid Fire Abstracts
Date: 1 September 2019
Time: 11:00 - 12:30

Congress Session

9 presentations in this session

Sequential nephron blockade with diuretics improves diastolic dysfunction in patients with resistant hypertension, a substudy a the PHARES trial

Speaker: Doctor D. Fouassier (Paris, FR)
Thumbnail

Inhaled iloprost, exercise hemodynamics, and ventricular performance in heart failure with preserved ejection fraction

Speaker: Doctor J. Cheng (Pingtung, TW)
Thumbnail

Drug effect of luseogliflozin and voglibose on heart failure with preserved ejection fraction in diabetic patients: a multicenter randomized-controlled trial

Speaker: Doctor H. Kihara (Asahikawa, JP)
Thumbnail

Diuretic and renal effects of spironolactone and heart failure hospitalizations: A TOPCAT Americas analysis

Speaker: Associate Professor A. Kalogeropoulos (Stony Brook, US)
Thumbnail

Use of phenomapping to determine response of treatment by sacubitril/valsartan in patients with heart failure with reduced ejection fraction

Speaker: Mr M. Godet (Rouen, FR)
Thumbnail

Clinical predictors of NT-proBNP response to early initiation of sacubitril/valsartan after hospitalisation for decompensated heart failure: An analysis of the TRANSITION study

Speaker: Doctor D. Pascual Figal (Murcia, ES)
Thumbnail

The effect of eplerenone on fibrosis in hypertrophic cardiomyopathy. A randomised controlled trial assessed using cardiopulmonary exercise testing and cardiovascular magnetic resonance

Speaker: Doctor Y. Bhatti (London, GB)
Thumbnail

Effect of beta-blocker dose on the prognosis in chronic heart failure patients depending on the presence of atrial fibrillation. Data from FAR NHL (FARmacology and NeuroHumoraL activation) registry.

Speaker: Assistant Professor K. Labr (Brno, CZ)
Thumbnail

Vasodilator challenge with levosimendan as alternative to nitric oxide in advanced heart failure heart transplant candidates

Speaker: Doctor M. Tavares Da Silva (Porto, PT)
Thumbnail

9 speakers from this session

Doctor David Fouassier

ICPC Turin (Institut Cœur Paris Centre), Paris (France)
0 follower

Doctor Jen-Fang Cheng

Pingtung Hospital, Pingtung (Taiwan)
0 follower

Doctor Hajime Kihara

Kihara Cardiovascular Clinic, Asahikawa (Japan)
0 follower

Associate Professor Andreas Kalogeropoulos

Stony Brook University, Stony Brook (United States of America)
1 presentation
0 follower

Mr Matthieu Godet

University of Rouen, Rouen (France)
0 follower

Doctor Domingo Pascual Figal

Virgen de la Arrixaca University Clinical Hospital, Murcia (Spain)
1 presentation
1 follower

Doctor Yousaf Bhatti

St Bartholomews and Queen Mary University, London (United Kingdom of Great Britain & Northern Ireland)
0 follower

Assistant Professor Karel Labr

St. Anne University Hospital Brno (FNUSA), Brno (Czechia)
0 follower

Doctor Marta Tavares Da Silva

Sao Joao Hospital, Porto (Portugal)
3 presentations
0 follower

This platform is supported by

logo Novo Nordisk